You are here

  • Home
  • Archive
  • Volume 60, Issue 5
  • Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor α blocking treatment

Article Text

Article menu
Download PDFPDF
Concise report
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor α blocking treatment
  1. A A den Broeder,
  2. F H J van den Hoogen,
  3. L B A van de Putte
  1. Department of Rheumatology, University Medical Centre Nijmegen, The Netherlands
  1. Dr A A den Broeder, Department of Rheumatology, University Medical Centre Nijmegen' PO Box 9101, 6500 HB Nijmegen, The NetherlandsA.denbroeder{at}reuma.azn.nl

Abstract

Tumour necrosis factor α (TNFα) blocking agents are among the most promising new treatments for rheumatoid arthritis (RA). However, no data exist about the effect of these agents on extra-articular manifestations of RA. A patient is described with small vessel vasculitis that repeatedly responded well to treatment with the soluble p55 TNFα receptor fusion protein Ro 45-2081 (lenercept).

  • digital vasculitis
  • tumour necrosis factor α

https://doi.org/10.1136/ard.60.5.538

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text